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In the title compound, C6H10N2O, the 2,3-dihydro-1H-
pyrazole ring is approximately planar, with a maximum
deviation of 0.013 (1) A ˚ . Pairs of intermolecular N—H   O
hydrogen bonds link neighboring molecules into dimers,
generating R2
2(8) ring motifs. These dimers are further linked
into two-dimensional arrays parallel to the bc plane by
intermolecular N—H   O hydrogen bonds. The crystal
structure is further stabilized by C—H     interactions.
Related literature
For the background to and the biological activity of 3-ethyl-4-
methyl-1H-pyrazol-5-ol, see: Brogden (1986); Coersmeier et
al. (1986); Gursoy et al. (2000); Ragavan et al. (2009, 2010);
Watanabe et al. (1984); Kawai et al. (1997); Wu et al. (2002).
For related structures, see: Shahani et al. (2009, 2010). For
hydrogen-bond motifs, see: Bernstein et al. (1995). For refer-
ence bond-length data, see: Allen et al. (1987). For the stability
of the temperature controller used for the data collection, see:






a = 8.374 (2) A ˚
b = 7.2881 (16) A ˚
c = 11.300 (3) A ˚
  = 109.955 (5) 
V = 648.3 (3) A ˚ 3
Z =4
Mo K  radiation
  = 0.09 mm
 1
T = 100 K
0.52   0.16   0.09 mm
Data collection




Tmin = 0.954, Tmax = 0.992
10018 measured reﬂections
2745 independent reﬂections











All H-atom parameters reﬁned
 max = 0.52 e A ˚  3
 min =  0.35 e A ˚  3
Table 1
Hydrogen-bond geometry (A ˚ ,  ).
Cg1 is the centroid of the 1H-pyrazole ring (C1–C3/N1/N2).
D—H   AD —H H   AD    AD —H   A
N1—H1N1   O1
i 0.902 (15) 1.829 (15) 2.7267 (11) 174.0 (16)
N2—H1N2   O1
ii 0.972 (14) 1.715 (14) 2.6777 (10) 169.9 (13)
C5—H5A   Cg1
iii 1.013 (13) 2.896 (15) 3.6749 (14) 134.2 (11)
Symmetry codes: (i)  x þ 1; y þ 1; z; (ii) x; y þ 3
2;z   1
2; (iii)  x;y þ 1
2; z   1
2.
Data collection: APEX2 (Bruker, 2009); cell reﬁnement: SAINT
(Bruker, 2009); data reduction: SAINT; program(s) used to solve
structure: SHELXTL (Sheldrick, 2008); program(s) used to reﬁne
structure: SHELXTL; molecular graphics: SHELXTL; software used
to prepare material for publication: SHELXTL and PLATON (Spek,
2009).
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5-Ethyl-4-methyl-1H-pyrazol-3(2H)-one
T. Shahani, H.-K. Fun, R. V. Ragavan, V. Vijayakumar and S. Sarveswari
Comment
Pyrazolone derivatives have a broad spectrum of biological activities as analgesic, antipyretic and anti-inflammatory thera-
peutical drugs (Brogden, 1986; Gursoy et al., 2000). A class of new pyrazolone compounds have been synthesized and
reported to exhibit antibacterial and antifungal activities (Ragavan et al., 2010; Ragavan et al., 2009). A new pyrazolone de-
rivative, edaravone (5-ethyl-4-methyl-1H-pyrazol-3(2H)-one), is being used as a drug in clinical practice for brain ischemia
(Watanabe et al., 1984; Kawai et al., 1997) and it has also been found to be effective against myocardial ischemia (Wu
et al., 2002).
In the crystal structure (Fig. 1), the 2,3-dihydro-1H-pyrazole ring (C1–C3/N1/N2) is approximately planar with a max-
imum deviation of 0.013 (1) Å for atoms N1 and N2 (but they are on opposite sides of the plane). The bond lengths (Allen
et al., 1987) and angles are within normal ranges and comparable to those in closely related structures reported recently
(Shahani et al., 2009; 2010).
In the crystal packing (Fig. 2), pairs of intermolecular N1—H1N1···O1 hydrogen bonds (Table 1) link neighboring mo-
lecules into dimers, generating R2
2(8) ring motifs (Bernstein et al., 1995). These dimers are further linked into 2D arrays
parallel to the bc plane by intermolecular N2—H1N2···O1 hydrogen bonds (Table 1). The crystal structure is further stabil-
ized by a C—H···π interaction (Table 1), involving the C1–C3/N1/N2 ring (centroid Cg1) .
Experimental
The compound 5-ethyl-4-methyl-1H-pyrazol-3(2H)-one has been synthesized using the method reported in the literature
(Ragavan et al., 2009, 2010) and purified by column chromatography (MeOH: EtOAc, 1:99). It was recrystallised as a
colourless solid, using ethanol. Mp: 496.4–507.1 K; MS calculated for C6H10N2O: 126.15. Found: 128.0 (M+).
Refinement
All hydrogen atoms were located in a difference map and were refined freely [N–H = 0.902 (14) – 0.972 (14) Å; C–H =
0.989 (13) – 1.015 (13) Å].supplementary materials
sup-2
Figures
Fig. 1. The molecular structure of the title compound, showing 30% probability displacement
ellipsoids and the atom numbering scheme. Hydrogen atoms are shown as spheres of arbitrary
radius.
Fig. 2. The crystal packing of the title compound, showing a 2D array parallel to the bc plane.
Hydrogen bonds are denoted by dashed lines. H atoms not involved in the hydrogen bond in-
teractions have been omitted for clarity.
5-Ethyl-4-methyl-1H-pyrazol-3(2H)-one
Crystal data
C6H10N2O F(000) = 272
Mr = 126.16 Dx = 1.293 Mg m−3
Monoclinic, P21/c Mo Kα radiation, λ = 0.71073 Å
Hall symbol: -P 2ybc Cell parameters from 3666 reflections
a = 8.374 (2) Å θ = 2.6–34.5°
b = 7.2881 (16) Å µ = 0.09 mm−1
c = 11.300 (3) Å T = 100 K
β = 109.955 (5)° Plate, colourless
V = 648.3 (3) Å3 0.52 × 0.16 × 0.09 mm
Z = 4
Data collection
Bruker APEXII DUO CCD area-detector
diffractometer 2745 independent reflections
Radiation source: fine-focus sealed tube 2325 reflections with I > 2σ(I)
graphite Rint = 0.029
φ and ω scans θmax = 34.6°, θmin = 3.4°
Absorption correction: multi-scan
(SADABS; Bruker, 2009) h = −13→13supplementary materials
sup-3
Tmin = 0.954, Tmax = 0.992 k = −11→11
10018 measured reflections l = −18→17
Refinement
Refinement on F2 Primary atom site location: structure-invariant direct
methods
Least-squares matrix: full Secondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.039
Hydrogen site location: inferred from neighbouring
sites
wR(F2) = 0.123 All H-atom parameters refined
S = 1.14
w = 1/[σ2(Fo
2) + (0.0715P)2 + 0.0472P]
where P = (Fo
2 + 2Fc
2)/3
2745 reflections (Δ/σ)max < 0.001
122 parameters Δρmax = 0.52 e Å−3
0 restraints Δρmin = −0.35 e Å−3
Special details
Experimental. The crystal was placed in the cold stream of an Oxford Cyrosystems Cobra open-flow nitrogen cryostat (Cosier &
Glazer, 1986) operating at 100.0 (1) K.
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The
cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds
in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used
for estimating esds involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, convention-
al R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-
factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large
as those based on F, and R- factors based on ALL data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)
x y z Uiso*/Ueq
O1 0.42822 (7) 0.62337 (8) 0.11992 (5) 0.01463 (13)
N1 0.42529 (8) 0.69441 (9) −0.08076 (6) 0.01353 (13)
N2 0.35794 (9) 0.82809 (9) −0.16813 (6) 0.01431 (13)
C1 0.38533 (9) 0.73007 (10) 0.02374 (6) 0.01110 (13)
C2 0.29351 (9) 0.89787 (9) 0.00188 (6) 0.01142 (13)
C3 0.28136 (9) 0.95309 (10) −0.11791 (7) 0.01249 (14)
C4 0.19811 (10) 1.11714 (10) −0.19250 (7) 0.01638 (15)
C5 0.05452 (11) 1.06785 (12) −0.31308 (8) 0.02089 (17)
C6 0.22769 (10) 0.99011 (11) 0.09370 (7) 0.01700 (15)
H4A 0.1538 (18) 1.1950 (18) −0.1386 (13) 0.026 (3)*
H4B 0.2822 (16) 1.1904 (17) −0.2159 (11) 0.019 (3)*
H5A −0.0064 (17) 1.1779 (18) −0.3632 (13) 0.025 (3)*
H5B −0.0336 (19) 0.991 (2) −0.2946 (14) 0.038 (4)*
H5C 0.0961 (19) 0.994 (2) −0.3704 (15) 0.036 (4)*supplementary materials
sup-4
H6A 0.3195 (17) 1.0187 (18) 0.1773 (13) 0.027 (3)*
H6B 0.147 (2) 0.9115 (19) 0.1185 (14) 0.033 (4)*
H6C 0.163 (2) 1.103 (2) 0.0557 (16) 0.044 (4)*
H1N1 0.4808 (19) 0.5936 (19) −0.0921 (14) 0.028 (3)*
H1N2 0.3762 (17) 0.8332 (19) −0.2486 (13) 0.028 (3)*
Atomic displacement parameters (Å2)
U11 U22 U33 U12 U13 U23
O1 0.0221 (3) 0.0147 (2) 0.0089 (2) 0.00498 (18) 0.00754 (19) 0.00296 (17)
N1 0.0211 (3) 0.0125 (3) 0.0092 (2) 0.0048 (2) 0.0080 (2) 0.00233 (19)
N2 0.0221 (3) 0.0130 (3) 0.0098 (3) 0.0033 (2) 0.0080 (2) 0.0027 (2)
C1 0.0144 (3) 0.0120 (3) 0.0078 (3) 0.0006 (2) 0.0050 (2) −0.0002 (2)
C2 0.0142 (3) 0.0109 (3) 0.0096 (3) 0.0009 (2) 0.0047 (2) −0.0003 (2)
C3 0.0159 (3) 0.0106 (3) 0.0110 (3) 0.0000 (2) 0.0047 (2) 0.0000 (2)
C4 0.0213 (3) 0.0118 (3) 0.0143 (3) 0.0012 (2) 0.0039 (3) 0.0027 (2)
C5 0.0212 (3) 0.0193 (3) 0.0178 (3) 0.0024 (3) 0.0010 (3) 0.0032 (3)
C6 0.0208 (3) 0.0187 (3) 0.0132 (3) 0.0048 (3) 0.0079 (3) −0.0015 (3)
Geometric parameters (Å, °)
O1—C1 1.2839 (9) C4—C5 1.5209 (12)
N1—C1 1.3578 (9) C4—H4A 0.993 (14)
N1—N2 1.3645 (9) C4—H4B 0.989 (13)
N1—H1N1 0.902 (14) C5—H5A 1.013 (13)
N2—C3 1.3459 (10) C5—H5B 1.003 (15)
N2—H1N2 0.972 (14) C5—H5C 0.992 (16)
C1—C2 1.4206 (10) C6—H6A 1.015 (13)
C2—C3 1.3823 (10) C6—H6B 0.994 (15)
C2—C6 1.4908 (10) C6—H6C 1.000 (16)
C3—C4 1.4916 (11)
C1—N1—N2 109.19 (6) C5—C4—H4A 109.8 (8)
C1—N1—H1N1 124.9 (9) C3—C4—H4B 110.2 (7)
N2—N1—H1N1 125.8 (9) C5—C4—H4B 107.8 (7)
C3—N2—N1 108.49 (6) H4A—C4—H4B 107.7 (11)
C3—N2—H1N2 128.1 (8) C4—C5—H5A 114.0 (8)
N1—N2—H1N2 123.1 (8) C4—C5—H5B 111.0 (9)
O1—C1—N1 122.64 (7) H5A—C5—H5B 106.9 (12)
O1—C1—C2 130.32 (6) C4—C5—H5C 111.5 (9)
N1—C1—C2 107.04 (6) H5A—C5—H5C 106.6 (12)
C3—C2—C1 105.99 (6) H5B—C5—H5C 106.3 (12)
C3—C2—C6 128.98 (7) C2—C6—H6A 113.4 (8)
C1—C2—C6 125.03 (6) C2—C6—H6B 112.5 (9)
N2—C3—C2 109.23 (6) H6A—C6—H6B 103.1 (11)
N2—C3—C4 120.16 (7) C2—C6—H6C 110.4 (10)
C2—C3—C4 130.59 (7) H6A—C6—H6C 110.9 (12)
C3—C4—C5 113.02 (7) H6B—C6—H6C 106.1 (13)
C3—C4—H4A 108.2 (8)supplementary materials
sup-5
C1—N1—N2—C3 2.59 (8) N1—N2—C3—C4 179.19 (6)
N2—N1—C1—O1 177.88 (7) C1—C2—C3—N2 0.73 (8)
N2—N1—C1—C2 −2.09 (8) C6—C2—C3—N2 −179.69 (7)
O1—C1—C2—C3 −179.13 (7) C1—C2—C3—C4 179.34 (7)
N1—C1—C2—C3 0.84 (8) C6—C2—C3—C4 −1.08 (13)
O1—C1—C2—C6 1.27 (12) N2—C3—C4—C5 60.72 (10)
N1—C1—C2—C6 −178.76 (7) C2—C3—C4—C5 −117.76 (9)
N1—N2—C3—C2 −2.03 (8)
Hydrogen-bond geometry (Å, °)
Cg1 is the centroid of the 1H-pyrazole ring (C1–C3/N1/N2).
D—H···A D—H H···A D···A D—H···A
N1—H1N1···O1i 0.902 (15) 1.829 (15) 2.7267 (11) 174.0 (16)
N2—H1N2···O1ii 0.972 (14) 1.715 (14) 2.6777 (10) 169.9 (13)
C5—H5A···Cg1iii 1.013 (13) 2.896 (15) 3.6749 (14) 134.2 (11)
Symmetry codes: (i) −x+1, −y+1, −z; (ii) x, −y+3/2, z−1/2; (iii) −x, y+1/2, −z−1/2.supplementary materials
sup-6
Fig. 1supplementary materials
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Fig. 2